AGP Executive Report
Last update: 10 hours agoWorld Heart Day 2026: The World Heart Federation’s “Don’t Miss a Beat” push highlights how heart disease can stay hidden until a heart attack or stroke, urging earlier screening and attention to warning signs. Supreme Court on drug pricing: India’s top court questioned why patients at corporate hospitals often buy essential medicines via in-house pharmacies at higher prices, probing the gap between retailer prices and MRP and what counts as “essential.” Cardiac risk in the young: Reports point to rising heart disease among people under 40, with experts linking earlier onset to lifestyle, stress, pollution and metabolic risk. Insomnia and brain health: A large review links insomnia with higher risk of stroke, hospitalisation and neurodegenerative diseases, including Alzheimer’s-related outcomes. US tariff relief for speciality drugs: The US granted India zero-tariff eligibility for specified speciality medicines and ingredients, offering targeted relief for pharma makers. Food safety enforcement: Delhi HC set aside an FSSAI order against Red Bull’s “Energy Drink” label, saying due process wasn’t followed, with FSSAI allowed to issue a fresh order. Healthcare access & regulation: A proposal to allow sale of prescription drugs only under CCTV surveillance is flagged as potentially useful for enforcement but raises privacy concerns around sensitive medicines.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
